Skip to main content

Table 3 Summary of five patients with compound heterozygosity in B3GAT3

From: Severe phenotypes of B3GAT3-related disorder caused by two heterozygous variants: a case report and literature review

Nationality/race/ethnicity

Consanguineous family

Age

Sex

Variant

Classification

Exon

Domain

Caucasian

Yes

4y

M

c.1A>G, p.M1?

LP

1

Cytoplasmic domain

    

c.671T>A, p.L224Q

VUS

4

Acceptor substrate binding subdomain

Italian

No

13y

F

c.481C>T, p.R161W

LP

3

Donor substrate binding subdomain

    

c.889C>T, p.R297W

LP

4

Acceptor substrate binding subdomain

Australian

No

Stillborn at 16 w

M

c.505C>T, p.R169W

D*

3

Donor substrate binding subdomain

    

c.673C>T, p.R225*

LP

4

Acceptor substrate binding subdomain

  

Deceased at 9m

F

c.505C>T, p.R169W

D*

3

Donor substrate binding subdomain

    

c.673C>T, p.R225*

LP

4

Acceptor substrate binding subdomain

Chinese

No

2m

M

c.752T>C, p.V251A

VUS

4

Acceptor substrate binding subdomain

    

c.47C>A, p.S16*

LP

1

Transmembrane domain

  1. y year, m month, w week, Male M, Female F, LP likely pathogenic, VUS variant of uncertain significance, D predicted to be deleterious by multiple lines of computational evidences
  2. *Not an ACMG classification